Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 24 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 11091495

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  2. US 11084798

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  3. US 11083720

    Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  4. US 11084809

    N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  5. US 11078205

    Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 11071727

    Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene product (MLL1) by taspase1 using kinase inhibitors

    Northwestern University · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  7. US 11072581

    N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

    Oxford Drug Design Limited · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  8. US 11072600

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  9. US 11066420

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  10. US 11065254

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  11. US 11066360

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  12. US 11058688

    Imidazopiperazine inhibitors of transcription activating proteins

    The Board of Regents of the University of Texas System · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  13. US 11058704

    Inhibitors of adenosine 5′-nucleotidase

    Arcus Biosciences, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  14. US 11059814

    Kinase inhibitors and methods for making and using

    Rigel Pharmaceuticals, Inc. · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted
  15. US 11046691

    2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

    IDEAYA Biosciences, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  16. US 11045461

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  17. US 11046649

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  18. US 11046709

    Fused 1,4-diazepines as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  19. US 11045448

    Piperidines as covalent menin inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  20. US 11040029

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  21. US 11041000

    Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

    Protagonist Therapeutics, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  22. US 11040027

    Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

    HEPAREGENIX GMBH · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  23. US 11034705

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted
  24. US 11033560

    Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted